Literature DB >> 6931252

Plasminogen activator content of human colon tumors and normal mucosae: separation of enzymes and partial purification.

J G Corasanti, C Celik, S M Camiolo, A Mittelman, J L Evers, A Barbasch, G H Hobika, G Markus.   

Abstract

Plasminogen activator content was determined quantitatively in extracts of 23 pairs of surgically removed colon tumors and adjacent normal mucosa specimens. The activator content averaged 4.4 times higher in the tumor samples than in the corresponding normal tissue. Polyps removed with the adenocarcinomas gave values intermediate between those for tumors and those for the normal mucosae. The enzyme content of the group of tumors that showed invasive propagation or metastatic spread was significantly higher (P < 0.05) than was the enzyme content of the group not manifesting these conditions. Activator activity of the tumor extracts was completely inhibited by rabbit antibody formed against human urokinse. The activity of the normal mucosae was variably inhibited, suggesting the presence of several kinds of activator in normal tissues. The activator from the normal tissues could be separated into a completely refractory fraction and a completely inhibitable fraction by means of an affinity column made of Sepharose-linked, rabbit antiurokinase antibody. The activator, eluted from this column with 1 M acetic acid in 0.5 M NaCl (pH 2.2), was highly purified and had an isoelectric point of 8.6, as does authentic urokinase. The details of the isoelectric profile of the two, however, differed. The data are discussed in relation to earlier studies on the fibrinolytic system in colon cancer.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6931252

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  13 in total

1.  Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future Prospects.

Authors:  Manfred Schmitt; Karin Mengele; Apostolos Gkazepis; Rudolf Napieralski; Viktor Magdolen; Ute Reuning; Nadia Harbeck
Journal:  Breast Care (Basel)       Date:  2008-10-15       Impact factor: 2.860

2.  Identification of a plasminogen activator derived from nasopharyngeal carcinoma.

Authors:  T Kosugi; G W Huang; M Nakamura; S Koja; H T Nong
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

3.  Plasminogen activators in human colorectal neoplasia.

Authors:  J S Gelister; M Mahmoud; M R Lewin; P J Gaffney; P B Boulos
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-20

4.  A novel leupeptin-sensitive serine endopeptidase present in normal and malignant rat mammary tissues.

Authors:  I Eto; M D Bandy
Journal:  Mol Cell Biochem       Date:  1990-04-18       Impact factor: 3.396

5.  In situ stromal expression of the urokinase/plasmin system correlates with epithelial dysplasia in colorectal adenomas.

Authors:  I Sordat; P Chaubert; P Protiva; L Guillou; L Mazzucchelli; E Saraga; J Benhattar; C Trân-Thang; A L Blum; G Dorta; B Sordat
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

6.  Induction of urokinase-type plasminogen activator by UV light in human fetal fibroblasts is mediated through a UV-induced secreted protein.

Authors:  N Rotem; J H Axelrod; R Miskin
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

7.  Elevated urokinase-type plasminogen activator plasma levels are associated with deterioration of liver function but not with hepatocellular carcinoma.

Authors:  S Sato; T Higashi; S Ouguchi; N Hino; T Tsuji
Journal:  J Gastroenterol       Date:  1994-12       Impact factor: 7.527

8.  Cell associated urokinase activity and colonic epithelial cells in health and disease.

Authors:  P R Gibson; E van de Pol; W F Doe
Journal:  Gut       Date:  1991-02       Impact factor: 23.059

9.  Effect of dimethyl sulfoxide on human carcinoma cells, inhibition of plasminogen activator synthesis, change in cell morphology, and alteration of response to cholera toxin.

Authors:  L Ossowski; D Belin
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

10.  Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas.

Authors:  C Pyke; P Kristensen; E Ralfkiaer; J Grøndahl-Hansen; J Eriksen; F Blasi; K Danø
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.